Windtree Therapeutics, Inc.
WINT
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.80M | 1.82M | 1.73M | 2.77M | 1.59M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.98M | 4.09M | 3.92M | 4.74M | 11.45M |
Operating Income | -3.98M | -4.09M | -3.92M | -4.74M | -11.45M |
Income Before Tax | -10.63M | -4.05M | 2.69M | -2.99M | -11.83M |
Income Tax Expenses | -- | -- | -77.00K | -240.00K | 197.00K |
Earnings from Continuing Operations | -10.63M | -4.05M | 2.77M | -2.75M | -12.02M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -10.63M | -4.05M | 2.77M | -2.75M | -12.02M |
EBIT | -3.98M | -4.09M | -3.92M | -4.74M | -11.45M |
EBITDA | -3.97M | -4.07M | -3.90M | -4.69M | -11.43M |
EPS Basic | -3.06 | -4.63 | 0.40 | -211.39 | -1.05K |
Normalized Basic EPS | -1.37 | -2.31 | 16.24 | -107.81 | -642.94 |
EPS Diluted | -3.06 | -4.63 | 0.40 | -211.39 | -1.05K |
Normalized Diluted EPS | -1.37 | -2.31 | 16.24 | -107.81 | -642.94 |
Average Basic Shares Outstanding | 4.88M | 1.09M | 171.80K | 17.70K | 11.50K |
Average Diluted Shares Outstanding | 4.88M | 1.09M | 171.80K | 17.70K | 11.50K |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | 0.00% | -2.22% | 11.20% | -12.62% | -- |